Basic Information
| LncRNA/CircRNA Name | LINC01503 |
| Synonyms | NA |
| Region | GRCh38_9:129332300-129359538 |
| Ensemble | ENSG00000233901 |
| Refseq | NR_120685 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | glioma tissue and cell lines( U251,LN299 ) |
| Expression Pattern | up-regulated |
| Function Description | We found that LINC01503 expression level was significantly up-regulated in glioma tissue and cells, and that its overexpression was significantly correlated with KPS, tumor size and WHO grade in glioma patients. |
| Pubmed ID | 30840283 |
| Year | 2019 |
| Title | Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt/?-catenin signaling. |
External Links
| Links for LINC01503 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |